WOCKHARDT
|
The Current P/S Ratio of WOCKHARDT is 9.77.
| Share Price | ₹2,027.1 | Aug 03,2026 |
| Market Cap | ₹32,939.6 Cr | |
| Sales-TTM | ₹3,373.0 Cr | TTM-Consolidated Results |
| Price/Sales | 9.77x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WOCKHARDT
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹32,939.6 Cr] as on Aug 03,2026
(/) Sales [ ₹3,373.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.77x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '9.77 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WOCKHARDT !
The chart below summarizes the trend in P/S Ratio of WOCKHARDT over the last five years.
Historical PS (Price/Sales) ratio chart of WOCKHARDT
PS Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.71x.
- WOCKHARDT 's operated at median p/e ratio of 3.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2025 at 7.66x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2023 of 0.84x.
How does WOCKHARDT 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WOCKHARDT | 3,373.0 | 9.77 | 32,939.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.81 | 467,870.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.67 | 220,946.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.14 | 190,907.0 |
| CIPLA LTD | 28,324.4 | 4.19 | 118,674.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.94 | 97,648.7 |
| MANKIND PHARMA LTD | 14,737.9 | 6.93 | 102,194.0 |
| LUPIN LTD | 27,958.0 | 3.89 | 108,639.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.10 | 111,346.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.72 | 91,542.6 |
| LAURUS LABS LTD | 7,269.6 | 13.46 | 97,850.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WOCKHARDT 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.72x |
| Max industry PS | 19.67x |
| Median industry PS | 6.93x |
| Average industry PS | 7.97x |
You may also like the below Video Courses